Abiopharma

🔍 Garrett Mary (Director)

Company: PROCEPT BioRobotics Corp (PRCT)

Report Date: 2026-06-09

Detailed Transactions and Holdings:

• Acquired 3,315 shares of Common Stock (Direct)
  Date: 2026-06-09 | Code: A | equity_swap_involved: 0 | shares_owned_after: 17,700.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 5,853 shares of Stock Option (Right to Buy) at $28.78 per share (Derivative)
  Date: 2026-06-09 | Code: A | Expires: 2036-06-08 | equity_swap_involved: 0 | shares_owned_after: 5,853.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.
• F2: The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.